As a GLP-1 receptor agonist, it helps regulate appetite, improve metabolic health, and promote overall well-being
Upon administration, it binds to and activates GLP-1 receptors distributed throughout the body, including pancreatic beta cells, the gastrointestinal tract, and specific regions of the central nervous system
Our service connects you with board-certified physicians who will evaluate your health history and determine if GLP-1 treatment is appropriate for you
A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes
Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy